Biostar Pharmaceuticals Inc Share Price Nasdaq
Equities
US0906782026
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2015 | 27.13M 2.17B | Sales 2016 | 2.38M 191M | Capitalization | 7.73M 618M |
---|---|---|---|---|---|
Net income 2015 | -25M -2B | Net income 2016 | -5M -400M | EV / Sales 2015 | 0.33 x |
Net Debt 2015 | 2.73M 219M | Net Debt 2016 | 2.15M 172M | EV / Sales 2016 | 4.14 x |
P/E ratio 2015 |
-0.25
x | P/E ratio 2016 |
-1.17
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Rong Hua Wang
CEO | Chief Executive Officer | 69 | 26/03/07 |
Xiaojuan Zhai
DFI | Director of Finance/CFO | - | 04/02/17 |
Zheng Hong Wang
COO | Chief Operating Officer | 43 | 29/02/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rong Hua Wang
CEO | Chief Executive Officer | 69 | 26/03/07 |
Hai Peng Wu
BRD | Director/Board Member | 66 | 30/06/07 |
Zhan Xiang Ma
BRD | Director/Board Member | - | 28/01/18 |
1st Jan change | Capi. | |
---|---|---|
+33.25% | 699B | |
+24.91% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.68% | 236B | |
+4.87% | 198B | |
-10.27% | 194B | |
-3.69% | 149B |